Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HSPA1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HSPA1A is a protein involved in neurodegeneration research. Key relationships include: associated with, activates, expressed in. Associated with AD, ALI, ALS. Connected to 518 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | HSPA1A |
| Full Name | Heat Shock 70 kDa Protein 1A (Hsp70-1A) |
| Aliases | HSP70-1A, HSP70, Hsp70 |
| Protein Family | Hsp70 family |
| Protein Type | Chaperone |
| Target Class | Chaperone |
| Function | Small molecule activators or allosteric modulators of chaperone function |
| Mechanism of Action | Small molecule activators or allosteric modulators of chaperone function |
| Subcellular Localization | Cytoplasm, Nucleus, Cell membrane |
| Druggability | Medium (0.46) |
| Clinical Stage | Phase III |
| Molecular Weight | ~70 kDa |
| Pathways | Akt, Chaperone, ERK/JNK Pathway, Erk/Jnk Pathway, Lipid Metabolism |
| UniProt ID | P0DMV8 |
| GeneCards | HSPA1A |
| Human Protein Atlas | HSPA1A |
| Associated Diseases | AD, AGE_RELATED_DISEASES, Aging, ALI, Als |
| Known Drugs/Compounds | KNK437, RN5S, Trna |
| Interactions | ACSL4, ager, AGER, AGING, ALOX15, ALS |
| SciDEX Target | View Target Profile (6 clinical trials) |
| SciDEX Hypotheses | Proteostasis Enhancement via APOE Chaperone Target Heat Shock Protein 70 Disaggregase Amplification |
| KG Connections | 942 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
HSPA1A(["HSPA1A"])
Reactive_Oxygen_Species["Reactive Oxygen Species"]
Prostatic_Epithelium["Prostatic Epithelium"]
ERK_JNK_Pathway["ERK/JNK Pathway"]
Traumatic_Spinal_Cord_Injury["Traumatic Spinal Cord Injury"]
Functional_Recovery("Functional Recovery")
Oligodendrocytes["Oligodendrocytes"]
HELLP_Syndrome["HELLP Syndrome"]
h_5dbfd3aa["h-5dbfd3aa"]
h_637a53c9["h-637a53c9"]
h_74777459["h-74777459"]
Benign_Prostatic_Hyperplasia["Benign Prostatic Hyperplasia"]
Cell_Proliferation("Cell Proliferation")
HSPA1A -.->|"inhibits"| Reactive_Oxygen_Species
HSPA1A -->|"expressed in"| Prostatic_Epithelium
HSPA1A -->|"regulates"| ERK_JNK_Pathway
HSPA1A -->|"protects against"| Traumatic_Spinal_Cord_Injury
HSPA1A -->|"associated with"| Functional_Recovery
HSPA1A -->|"expressed in"| Oligodendrocytes
HSPA1A -->|"biomarker for"| HELLP_Syndrome
h_5dbfd3aa -->|"therapeutic target"| HSPA1A
h_637a53c9 -->|"therapeutic target"| HSPA1A
h_74777459 -->|"therapeutic target"| HSPA1A
h_5dbfd3aa -->|"targets gene"| HSPA1A
h_637a53c9 -->|"targets gene"| HSPA1A
h_74777459 -->|"targets gene"| HSPA1A
HSPA1A -->|"biomarker for"| Benign_Prostatic_Hyperplasia
HSPA1A -->|"regulates"| Cell_Proliferation
style HSPA1A fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| RN5S | binds | compound | 0.95 |
| Trna | binds | compound | 0.95 |
| Benign Prostatic Hyperplasia | associated_with | disease | 0.95 |
| Erk/Jnk Pathway | regulates | pathway | 0.95 |
| Benign Prostatic Hyperplasia | involved_in | disease | 0.95 |
| Trna Gene Transcription | activates | process | 0.92 |
| Non-Coding Rna Biogenesis | involved_in | process | 0.92 |
| Prostatic Epithelium | expressed_in | cell_type | 0.92 |
| ERK/JNK Pathway | regulates | pathway | 0.90 |
| Therapeutic Target | targets | mechanism | 0.90 |
| Benign Prostatic Hyperplasia | implicated_in | disease | 0.90 |
| reactive oxygen species | suppresses | compound | 0.90 |
| Spinal Cord Injury | protects_against | disease | 0.90 |
| Erk/Jnk Pathway | modulates | pathway | 0.90 |
| Benign Prostatic Hyperplasia | upregulates | disease | 0.90 |
| HELLP Syndrome | biomarker_for | disease | 0.90 |
| Rna Polymerase Iii | regulates | enzyme | 0.90 |
| Hellp Syndrome | associated_with | disease | 0.90 |
| Traumatic Spinal Cord Injury | protects_against | disease | 0.90 |
| Cellular Homeostasis | associated_with | process | 0.90 |
| Benign Prostatic Hyperplasia | contributes_to | disease | 0.90 |
| Oligodendrocytes | expressed_in | cell_type | 0.90 |
| Functional Recovery | associated_with | phenotype | 0.90 |
| Benign Prostatic Hyperplasia | biomarker_for | disease | 0.88 |
| Cell Proliferation | regulates | process | 0.88 |
| sleep disorders | therapeutic_target | disease | 0.88 |
| Hepatocellular Injury | associated_with | process | 0.85 |
| ERK/JNK pathway | modulates | pathway | 0.85 |
| Protein Homeostasis | involved_in | process | 0.85 |
| Immunological Tolerance | associated_with | process | 0.85 |
| Preeclampsia | biomarker_for | disease | 0.85 |
| Age-Related Diseases | biomarker_for | disease | 0.85 |
| Apoptosis | suppresses | process | 0.85 |
| Parkinson's Disease | upregulates | disease | 0.85 |
| Multiple Sclerosis | upregulates | disease | 0.85 |
| Sleep | regulates | process | 0.85 |
| Preterm Delivery | risk_factor_for | disease | 0.85 |
| Alzheimer's Disease | upregulates | disease | 0.85 |
| Normal Pregnancy | downregulates | phenotype | 0.85 |
| Prostatic Stroma | expressed_in | cell_type | 0.85 |
| Prostate Volume | correlates_with | phenotype | 0.85 |
| KNK437 | targets | drug | 0.85 |
| DUSP1 | upregulates | protein | 0.85 |
| Apoptosis | involved_in | process | 0.85 |
| ERK/JNK pathway | activates | pathway | 0.80 |
| Apoptosis | regulates | process | 0.80 |
| BPH-1 cells | associated_with | cell_type | 0.80 |
| ERK/JNK pathway | associated_with | pathway | 0.80 |
| Immune Response | elicits | process | 0.80 |
| Maternal Immune Tolerance | promotes | process | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-637a53c9 | targets_gene | hypothesis | 0.90 |
| h-74777459 | targets_gene | hypothesis | 0.90 |
| h-5dbfd3aa | targets_gene | hypothesis | 0.90 |
| h-5d943bfc | targets_gene | hypothesis | 0.90 |
| ERK1/2 | interacts_with | gene | 0.90 |
| Testosterone-Induced BPH | upregulates | phenotype | 0.85 |
| TFE3 | regulates | gene | 0.80 |
| HSP90AA1 | regulates | protein | 0.80 |
| h-5dbfd3aa | targets | hypothesis | 0.80 |
| Necrotic Cells | associated_with | cell_type | 0.80 |
| h-74777459 | targets | hypothesis | 0.80 |
| h-637a53c9 | targets | hypothesis | 0.80 |
| Sleep | regulates | process | 0.75 |
| TP53 | regulates | entity | 0.70 |
| ATP | interacts_with | gene | 0.65 |
| HSP40 | activates | gene | 0.65 |
| ERK | treats | gene | 0.65 |
| KNK437 | inhibits | drug | 0.64 |
| DNAJB1 | interacts_with | gene | 0.61 |
| FKBP5 | interacts_with | gene | 0.61 |
| HSP90AA1 | interacts_with | gene | 0.61 |
| NF-ΚB | interacts_with | gene | 0.60 |
| CAPZB | therapeutic_target | gene | 0.60 |
| RAB5A | therapeutic_target | gene | 0.60 |
| AGER | interacts_with | gene | 0.60 |
| AGER | binds_to | gene | 0.60 |
| ZFP36 | therapeutic_target | gene | 0.60 |
| IL-6 | therapeutic_target | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| CANCER | interacts_with | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| NF-ΚB | expressed_in | gene | 0.60 |
| PHAGOCYTOSIS | expressed_in | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| SLC3A2 | regulates | gene | 0.60 |
| CANCER | biomarker_for | gene | 0.60 |
| HSPA1B | associated_with | gene | 0.60 |
| AGER | associated_with | gene | 0.60 |
| CEBPA | therapeutic_target | gene | 0.60 |
| CSF2 | regulates | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| FGF2 | regulates | gene | 0.60 |
| CXCL10 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Proteostasis Enhancement via APOE Chaperone Targeting | 0.724 | neurodegeneration | Mechanistic role of APOE in neurodegener |
| Heat Shock Protein 70 Disaggregase Amplification | 0.668 | neurodegeneration | TDP-43 phase separation therapeutics for |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.795
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.738
neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.836
neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.865
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| s:** - Dose-response studies showing therapeutic window without toxici | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Multiscale Computational Modeling of Protein Aggregation Kinetics | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Prion Strain Diversity and Selective Vulnerability in CJD | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proteasome-Ubiquitin System Dysfunction Validation in Parkinson's Dise | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Protein Aggregation Kinetic Validation Results | validation | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $120,000 |
| Experiment Validation: In vitro ThT Assay | validation | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $160,000 |
| Viral Infections and Alzheimer's Disease — causal mechanisms and thera | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress [PMID:40066224] | Liu H, Zhou Y, Wang Z, Liu D, Li Y, Lai | MedComm (2020) | 2025 | 1 |
| From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in [PMID:37643058] | Ghosh S, Vashisth K, Ghosh S, Han SS, Bh | J Biomol Struct Dyn | 2024 | 1 |
| Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteom [PMID:37652020] | Yuan S, Xu F, Li X, Chen J, Zheng J, Man | Cell Rep Med | 2023 | 1 |
| Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancie [PMID:19821156] | Molvarec A, Tamási L, Losonczy G, Madách | Cell Stress Chaperones | 2010 | 1 |
| Integrating NHANES and network toxicology to assess the impact of organophosphat [PMID:41804832] | Dai K, Huang Y, Cai H, Zhong G, Xie Z, W | Toxicology mechanisms and meth | 2026 | 0 |
| Crystal structures reveal phosphorylation-dependent disruption of the heat shock [PMID:41833837] | Stewart M, Paththamperuma C, McCann C, C | Cell stress & chaperones | 2026 | 0 |
| Aryl hydrocarbon receptor-mediated transcriptional regulation of HSP70 exacerbat [PMID:41725010] | Wen M, Li J, Li Y, Hun M, Yang T, Meng Y | Cell & bioscience | 2026 | 0 |
| Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via ne [PMID:41539636] | ["Fu X", "Long Q", "Wang Z", "Yan S", "L | Journal of ethnopharmacology | 2026 | 0 |
| Single-cell transcriptomics reveal heat shock protein dysregulation in severe SA [PMID:41772029] | Suzuki T, Sato Y, Suzuki M, Fukuda Y, Iw | Scientific reports | 2026 | 0 |
| Heat shock suppresses the innate immune response of bovine endometrial epithelia [PMID:41665179] | Tariq A, Sagheer M, Seekford ZK, Ren J, | Reproduction & fertility | 2026 | 0 |
| Single nucleus RNA sequencing profile analysis to reveal cell type specific comm [PMID:40715263] | Pappu MAA, Alamin M, Sultana MH | Sci Rep | 2025 | 0 |
| Downregulation of NEAT1 due to loss of TDP-43 function exacerbates motor neuron [PMID:40661327] | Kawakami Y, Iguchi Y, Li J | Brain Commun | 2025 | 0 |
| Echocardiography Versus Magnetic Resonance Imaging Quantification and Novel Algo [PMID:37890567] | ["Wang T", "Reyaldeen R", "Akyuz K", "Po | The American journal of cardio | 2024 | 0 |
| Integrating network pharmacology and drug side-effect data to explore mechanism [PMID:38308871] | ["Tang M", "Wu Z", "Li F"] | Computers in biology and medic | 2024 | 0 |
| Novel genetic insight for psoriasis: integrative genome-wide analyses in 863 080 [PMID:39883516] | Liu S, Li L, Liang Y, Tan Y, Wang X, Fen | Briefings in bioinformatics | 2024 | 0 |
| Lactate is an epigenetic metabolite that drives survival in model systems of gli [PMID:35948010] | Torrini C, Nguyen TTT, Shu C, Mela A, Hu | Molecular cell | 2022 | 0 |
| Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy agai [PMID:36567123] | ["Li J", "Yan Y", "Dou F", "Gao J"] | Bioscience trends | 2022 | 0 |
| Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular c [PMID:35164882] | ["Liu F", "Morderer D", "Wren M", "Vettl | Acta neuropathologica communic | 2022 | 0 |
| Salmon aquaculture threatens Patagonia. [PMID:33986174] | ["Juan G Navedo", "Luis Vargas-Chacoff"] | Science (New York, N.Y.) | 2021 | 0 |
| Re-identification of individuals in genomic datasets using public face images. [PMID:34788101] | Venkatesaramani R, Malin BA, Vorobeychik | Science advances | 2021 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.84 · 2026-04-12
closed · Rounds: 4 · Score: 0.95 · 2026-04-11
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 4 · Score: 0.87 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-01